Not Tagged
cellectis
['breast', 'cellectis']
 presents preclinical data on talen -edited muc1 car t-cells to enhance efficacy in targeting triple negative breast cancer at . to read the press release, click here: #aacr2023 #research #breastcancer 
Cellectis is gene editing the first of its kind, off-the-shelf UCART immunotherapies to fight blood cancers. Community Guidelines: https://t.co/PpAC8G7hQp